*|MC_PREVIEW_TEXT|*
Our coverage of the
American Society of Clinical Oncology (ASCO) 2020
Virtual Annual Meeting continues with highlights on treatments for prostate, lung and bladder cancer.
See our top picks below!
Neal Shore
HERO phase III trial in advanced prostate cancer
Martin Reck
CheckMate 9LA study: nivo + ipi in NSCLC
Vivek Subbiah
ARROW study: pralsetinib in RET fusion+ tumors
Thomas Powles
JAVELIN Bladder 100: avelumab maintenance
